Join our daily newsletter At The Bell to receive exclusive market insights
- Advanced Human Imaging (AHI) is gearing up to list on the NASDAQ, filing an F-1 Registration Statement with the US Securities and Exchange Commission (SEC)
- AHI says F-1 statements are filed with the SEC by non-US companies seeking to undertake an initial public offering (IPO) in the US before listing
- Under the offer, American Depositary Shares will represent a certain amount of AHI shares on issue, though the exact ratio is yet to be determined
- Once the IPO is complete, the healthcare stock will list on the NASDAQ under the ticker code AHI, after it recently reserving the code
- Shares in Advanced Human Imaging are down 2.14 per cent at $1.37 each
Advanced Human Imaging (AHI) is gearing up to list on the NASDAQ, filing an F-1 Registration Statement publicly with the US Securities and Exchange Commission (SEC).
AHI explained the F-1 was typically filed with the SEC by non-US companies seeking to undertake an initial public offering (IPO) in the US before listing.
The offer will see American Depositary Shares sold to investors, with each ADS representing a certain amount of AHI shares.
The exact ratio of ADS shares to AHI shares is yet to be determined, nor is the price of the shares or the offer opening date.
Ahead of the IPO, the healthcare stock has also appointed Lucosky Brookman as its legal counsel and PKF International to undertake accounting due diligence.
Additionally, AHI will work with Maxim Group as the lead underwriter of the issuance of ordinary shares under the offering.
Once the IPO is complete Advanced Human Imaging expects it will list on the NASDAQ under the ticker code AHI.
That code has been reserved for the business ahead of the listing, with AHI shares to continue operating on the ASX throughout the process and once the NASDAQ listing complete.
Following today’s announcement, shares in Advanced Human Imaging were down 2.14 per cent at $1.37 each at 12:14 pm AEST.
